A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to investigate the effect of itraconazole treatment in the
pharmacokinetics of RG1662. It is also to evaluate the exposure of RG1662 vs. QTc response
relationship and the safety and tolerability of RG1662 when given in combination with
itraconazole in healthy subjects.